In re Atossa Genetics, Inc. Securities Litig. (Levi v. Atossa Genetics, Inc.)
Plaintiffs pled a viable 10b-5 claim against defendant pharmaceutical company for representing that its cancer test was FDA-cleared when, in fact, the FDA had not yet approved the test. Read More